1. Home
  2. OVID vs MAPS Comparison

OVID vs MAPS Comparison

Compare OVID & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • MAPS
  • Stock Information
  • Founded
  • OVID 2014
  • MAPS 2008
  • Country
  • OVID United States
  • MAPS United States
  • Employees
  • OVID N/A
  • MAPS N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • MAPS Computer Software: Prepackaged Software
  • Sector
  • OVID Health Care
  • MAPS Technology
  • Exchange
  • OVID Nasdaq
  • MAPS Nasdaq
  • Market Cap
  • OVID 117.3M
  • MAPS 103.7M
  • IPO Year
  • OVID 2017
  • MAPS N/A
  • Fundamental
  • Price
  • OVID $1.32
  • MAPS $0.96
  • Analyst Decision
  • OVID Strong Buy
  • MAPS Strong Buy
  • Analyst Count
  • OVID 4
  • MAPS 1
  • Target Price
  • OVID $3.13
  • MAPS $2.61
  • AVG Volume (30 Days)
  • OVID 1.7M
  • MAPS 997.1K
  • Earning Date
  • OVID 11-13-2025
  • MAPS 11-06-2025
  • Dividend Yield
  • OVID N/A
  • MAPS N/A
  • EPS Growth
  • OVID N/A
  • MAPS N/A
  • EPS
  • OVID N/A
  • MAPS 0.07
  • Revenue
  • OVID $6,651,000.00
  • MAPS $179,305,000.00
  • Revenue This Year
  • OVID $1,081.80
  • MAPS N/A
  • Revenue Next Year
  • OVID N/A
  • MAPS $5.43
  • P/E Ratio
  • OVID N/A
  • MAPS $13.78
  • Revenue Growth
  • OVID 1070.95
  • MAPS N/A
  • 52 Week Low
  • OVID $0.24
  • MAPS $0.71
  • 52 Week High
  • OVID $2.01
  • MAPS $1.65
  • Technical
  • Relative Strength Index (RSI)
  • OVID 41.52
  • MAPS 37.78
  • Support Level
  • OVID $1.27
  • MAPS $0.97
  • Resistance Level
  • OVID $1.44
  • MAPS $1.04
  • Average True Range (ATR)
  • OVID 0.10
  • MAPS 0.06
  • MACD
  • OVID -0.04
  • MAPS -0.01
  • Stochastic Oscillator
  • OVID 14.29
  • MAPS 23.37

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About MAPS WM Technology Inc.

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.

Share on Social Networks: